Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this study is the safety and efficacy of Cetuximab plus natural killer(NK) immunotherapy to recurrent non-small cell lung cancer with EGFR mutation.
Epistemonikos ID: 3181f4a6baf49cb840993d93ee04605628f40753
First added on: May 17, 2024